AstraZeneca study points to new uses for targeted cancer drug Enhertu
Novo Nordisk enters talks to buy device maker Biocorp
Amgen's Horizon buyout delayed again, pushing closure possibly to December
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
*please scroll down for all the latest news*
